FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102880496> ?p ?o ?g. }

• W2102880496 endingPage "96" @default.
• W2102880496 startingPage "151" @default.
• W2102880496 abstract "Forty years ago, Lerner and coworkers (1958) discovered the first nonsteroidal antiestrogen and Jensen (Jensen and Jacobson, 1960) identified a target for drug action, the ER. This knowledge opened the door for the clinical development of tamoxifen which we now know provides a survival advantage in both node-positive and node-negative patients with ER-positive disease (Early Breast Cancer Trialists Collaborative Group, 1992, 1998). The drug has been studied extensively, and the results have provided an invaluable insight into possible ancillary advantages of antiestrogens, i.e., maintenance of bone density and the prevention of coronary heart disease, and possible disadvantages, i.e., rat liver carcinogenesis and an increased risk of endometrial cancer. Most importantly, the identification of the target site-specific actions of tamoxifen caused a paradigm shift in the prospective uses of antiestrogens from a direct exploitation of the antitumor properties to the broader application as a preventative for osteoporosis, but with the beneficial side effects of preventing breast and endometrial cancer. Raloxifene, a second-generation SERM, has all the properties in the laboratory that would encourage development as a safe preventative for osteoporosis (Jordan et al., 1997). As a result, raloxifene has been evaluated in more than 11,000 postmenopausal women and found to maintain bone density with significant decreases in breast cancer incidence and no increase in endometrial thickness. Raloxifene is now available as a preventative for osteoporosis in postmenopausal women. There is every reason to believe that a multifaceted agent like raloxifene will find widespread use, and there will be continuing interest by the pharmaceutical industry in the development of new agents with even broader applications. The extensive clinical effort is augmented by past molecular innovations in the laboratory and the future promise of new discoveries. The cloning and sequencing of the ER (Green et al., 1986; Greene et al., 1986) has allowed the development of an ER knock-out mouse (Lubahn et al., 1993) that compliments Jensen's pioneering work (Jensen and Jacobson, 1962) and describes the consequences of the loss of ER alpha. However, ER beta (Kuiper et al., 1996), the second ER, has provided an additional dimension to the description of estrogen and antiestrogen action. For the future, the development of ER beta monoclonal antibodies, the classification of target sites for the protein around the body, and the creation of ER beta and ER alpha, beta knock-out mice will identify new therapeutic targets to modulate physiological functions. Clearly, the successful crystallization of ER alpha with raloxifene (Brzozowski et al., 1997) must act as a stimulus for the crystallization of ER beta. The central issue for research on antiestrogen pharmacology is the discovery of the mechanism (or mechanisms) of target site-specificity for the modulation of estrogenic and antiestrogenic response. The description of a stimulatory pathway for antiestrogens through an AP-1 ER beta signal transduction pathway (Paech et al., 1997), although interesting, may not entirely explain the estrogenicity of antiestrogens. The model must encompass the sum of pharmacological consequences of signal transduction through ER alpha and ER beta with the simultaneous competition from endogenous estrogens at both sites. This is complicated because estradiol is an antagonist at ER beta through AP-1 sites (Paech et al., 1997), so this is clearly not the pathway for estrogen-induced bone maintenance in women. Estrogen is stimulatory through ER alpha, but antiestrogens are usually partial agonists and may either block or stimulate genes. However, we suggest that the ER alpha stimulatory pathway could be amplified through selective increases in coactivators. The principle is illustrated with the MDA-MB-231 cells stably transfected with the cDNAs for the wild-type and the amino acid 351 mutan" @default.
• W2102880496 created "2016-06-24" @default.
• W2102880496 creator A5005756055 @default.
• W2102880496 creator A5039580520 @default.
• W2102880496 date "1998-06-01" @default.
• W2102880496 modified "2023-10-01" @default.
• W2102880496 title "Basic guide to the mechanisms of antiestrogen action." @default.
• W2102880496 cites W110384481 @default.
• W2102880496 cites W1234520200 @default.
• W2102880496 cites W1488482346 @default.
• W2102880496 cites W1490750970 @default.
• W2102880496 cites W1493455044 @default.
• W2102880496 cites W1497990622 @default.
• W2102880496 cites W1500505511 @default.
• W2102880496 cites W1508336766 @default.
• W2102880496 cites W1510421758 @default.
• W2102880496 cites W1513409211 @default.
• W2102880496 cites W1514642917 @default.
• W2102880496 cites W1514843639 @default.
• W2102880496 cites W1519533002 @default.
• W2102880496 cites W1520299947 @default.
• W2102880496 cites W1520764408 @default.
• W2102880496 cites W1527874837 @default.
• W2102880496 cites W1527997452 @default.
• W2102880496 cites W1537442558 @default.
• W2102880496 cites W1539763820 @default.
• W2102880496 cites W1541817910 @default.
• W2102880496 cites W1545177906 @default.
• W2102880496 cites W1545992359 @default.
• W2102880496 cites W1548644314 @default.
• W2102880496 cites W1550220140 @default.
• W2102880496 cites W1555115548 @default.
• W2102880496 cites W1556176875 @default.
• W2102880496 cites W1559518404 @default.
• W2102880496 cites W1560420809 @default.
• W2102880496 cites W1562190372 @default.
• W2102880496 cites W1562784453 @default.
• W2102880496 cites W1563890385 @default.
• W2102880496 cites W1565310327 @default.
• W2102880496 cites W1569540889 @default.
• W2102880496 cites W1571431043 @default.
• W2102880496 cites W1583239328 @default.
• W2102880496 cites W1587127556 @default.
• W2102880496 cites W1608978897 @default.
• W2102880496 cites W1612068869 @default.
• W2102880496 cites W1618493953 @default.
• W2102880496 cites W1635906161 @default.
• W2102880496 cites W1642413975 @default.
• W2102880496 cites W1653672494 @default.
• W2102880496 cites W1663471795 @default.
• W2102880496 cites W169189322 @default.
• W2102880496 cites W1752892371 @default.
• W2102880496 cites W175672528 @default.
• W2102880496 cites W1784398948 @default.
• W2102880496 cites W1792161227 @default.
• W2102880496 cites W1805867622 @default.
• W2102880496 cites W1810933484 @default.
• W2102880496 cites W1825869840 @default.
• W2102880496 cites W1832761646 @default.
• W2102880496 cites W1842070729 @default.
• W2102880496 cites W1866210356 @default.
• W2102880496 cites W1869594139 @default.
• W2102880496 cites W1893154073 @default.
• W2102880496 cites W1906211198 @default.
• W2102880496 cites W1909697168 @default.
• W2102880496 cites W1911356127 @default.
• W2102880496 cites W1915537489 @default.
• W2102880496 cites W1925424309 @default.
• W2102880496 cites W1935820490 @default.
• W2102880496 cites W1936024593 @default.
• W2102880496 cites W1939457687 @default.
• W2102880496 cites W1944448503 @default.
• W2102880496 cites W1951021898 @default.
• W2102880496 cites W196155416 @default.
• W2102880496 cites W1962334164 @default.
• W2102880496 cites W1963125733 @default.
• W2102880496 cites W1963665803 @default.
• W2102880496 cites W1963741882 @default.
• W2102880496 cites W1964337986 @default.
• W2102880496 cites W1964520022 @default.
• W2102880496 cites W1964957120 @default.
• W2102880496 cites W1965325692 @default.
• W2102880496 cites W1965690290 @default.
• W2102880496 cites W1965903261 @default.
• W2102880496 cites W1966623655 @default.
• W2102880496 cites W1967113322 @default.
• W2102880496 cites W1968513785 @default.
• W2102880496 cites W1969883008 @default.
• W2102880496 cites W1970845854 @default.
• W2102880496 cites W1970972167 @default.
• W2102880496 cites W1971191564 @default.
• W2102880496 cites W1971628094 @default.
• W2102880496 cites W1971629719 @default.
• W2102880496 cites W1971861967 @default.
• W2102880496 cites W1971947104 @default.
• W2102880496 cites W1971960644 @default.
• W2102880496 cites W1972511021 @default.
• W2102880496 cites W1972708863 @default.

• next